POINT OF CARE DIAGNOSTICS MARKET ANALYSIS

Market Concentration and Competitive Landscape

Close-monitor your Competitor's Move, Request sample copy

Increasing prevalence of infectious diseases

Rising occurrences of infectious diseases can drive the point of care diagnostics market growth. Presence of various causal organisms and emergence of new pathogens threatens public health worldwide. Lack of clean water supplies and sanitation in developing countries along with increasing worldwide travel and trade can lead to spread of infectious maladies.

Prompt diagnosis is critical to curb the outbreak of contagious illnesses and prevent their transmission in the community. Traditional laboratory-based methods require transport of samples to centralized facilities and can take more than a day to yield results. This delays initiation of treatment and allows undetected spread during the gap period. Near-patient testing empowers healthcare professionals with faster diagnostic capabilities at the earliest stages of infection. It enables quick deployment of countermeasures like quarantine, contact tracing and administering necessary drugs/therapy depending on the in vitro analysis. This can curb potential epidemics at an initial stage itself before these can evolve into broader public health emergencies.

Rapid migration and cheaper international travel have led to higher chances of people getting exposed to exotic diseases in different parts of the world. Point of care assays can diagnose such infectious tropical disorders without having to send specimens to reference labs, sparing time for prompt care. These have become extremely useful diagnostic adjuncts in community health centers, physician offices, emergency departments and ambulatory surgical settings where infectious diseases are commonly encountered. Point of care testing provides a fast, convenient and reliable method to detect contagions promptly, and thus, is increasingly relied upon for combating growing onslaught of infectious pathogens.